LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹14 Cr | ₹9.72 Cr | ₹7.18 Cr | ₹0.39 Cr | ₹0.86 Cr |
What is the latest Secured Loans ratio of LYKA LABS ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹14 Cr |
| Mar2025 | ₹9.72 Cr |
| Mar2024 | ₹7.18 Cr |
| Mar2023 | ₹0.39 Cr |
| Mar2022 | ₹0.86 Cr |
How is Secured Loans of LYKA LABS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 Cr | 42.60 | |
| Mar2025 | ₹9.72 Cr | 35.48 | |
| Mar2024 | ₹7.18 Cr | 1,759.07 | |
| Mar2023 | ₹0.39 Cr | -55.06 | |
| Mar2022 | ₹0.86 Cr | - | |
Compare Secured Loans of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹301.9 Cr | 1.1% | 18.1% | -16% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 1.1% |
18.1% |
-16% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses